neuropeptide ei, rat

Displays functional MCH-antagonist and MSH-agonist activity in different behavioral paradigms.

Neuropeptide EI, rat acetate(125934-45-4 free base) 在不同的行为范例中显示功能性 MCH 拮抗剂和 MSH 激动剂活性。

Neuropeptide S (Rat) acetate 是以前孤儿 G 蛋白偶联受体的内源性配体，现在称为 NPS 受体。它可用于神经系统疾病的研究。

Neuropeptide SF(mouse,rat) acetate (Neuropeptide SF(mouse,rat) acetate (230960-31-3 free base)) 是一种有效的神经肽 FF 受体激动剂，对 NPFF1 和 NPFF2 的 Ki 分别为 48.4 nM 和 12.1 nM。它增加了异源表达的酸感应离子通道 3 (ASIC3) 的持续电流的幅度。

Neuropeptide Y (NPY) (3-36) is a C-terminal fragment of NPY, a neuropeptide involved in controlling appetite, blood pressure, cardiac contractility, and intestinal secretion. NPY (3-36) is an endogenous peptide produced by cleavage of NPY by dipeptidyl peptidase 4 (DPP-4). It binds selectively to the NPY receptor Y2 (Ki = 0.41 nM in CHP 234 cells) over the Y1 receptor, where it does not bind at concentrations up to 1 μM. NPY (3-36) (0.1 nM) increases migration of human umbilical vein endothelial cells (HUVECs) by 80% after 12 hours in an in vitro wound closure assay. NPY (3-36) corresponds to residues 3-36 of the human and rat protein sequence.

Potent endogenous neuropeptide S receptor (NSPR) agonist (EC50 = 3.2 nM). Increases locomotor activity and wakefulness in mice. Also reduces anxiety-like behavior in mice.

Neuropeptide Y (3-36) (human, rat) is a metabolite of neuropeptide Y (NPY) generated by dipeptidyl peptidase-4 (DPP4). Known as a selective Y2 receptor agonist, Neuropeptide Y (3-36) (human, rat) effectively reduces the release of norepinephrine via the Y2 receptor[1][2].

Neuropeptide SF (mouse,rat) TFA 作为一种高效的 neuropeptide FF receptor 激动剂，对 NPFF1 和 NPFF2 的Ki值分别达到 48.4 nM 和 12.1 nM。该化合物还能够提升异表达的酸感离子通道 3 (ASIC3) 的持续电流幅值。

High affinity neuropeptide Y Y1 receptor agonist (Ki = 0.39 nM). Also shows affinity for Y4 and Y5 receptors.

[Leu31,Pro34]-Neuropeptide Y(human,rat) TFA 是一种针对神经肽 YY1受体的特定激动剂，并亦能够激活Y4和Y5受体。该化合物能提高麻醉大鼠的血压并增加食物摄入。

Neuropeptide S(Rat) TFA, a robust endogenous agonist for the neuropeptide S receptor (NSPR) with an EC50 of 3.2 nM, enhances locomotor activity and promotes wakefulness while concurrently diminishing anxiety-like behavior in mice.